---
$id: https://graph.org.ai/products/commodity/51263123
$type: Product
source: UNSPSC
code: "51263123"
title: "Primidolol"
class: "51263100"
classTitle: "Adrenergic blocking agent propanolamines"
family: "51260000"
familyTitle: "Adrenergic blocking agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Primidolol

**UNSPSC Code**: 51263123
**Class**: [Adrenergic blocking agent propanolamines](Adrenergic blocking agent propanolamines.mdx)
**Family**: [Adrenergic blocking agents](../Adrenergic blocking agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a beta-adrenergic blocking agent with the molecular formula C17H23N3O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56QH73D78K, chemically known as 2,4-(1h,3h)-pyrimidinedione, 1-(2-((2-hydroxy-3-(2-methylphenoxy)propyl)amino)ethyl)-5-methyl- but generally known as primidolol, which bears US NIH Compound Identifier 68563. European Medicines Agency schedules Primidolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10044MIG. The term PRIMIDOLOL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, No. 10 1980, List 20). PRIMIDOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule primidolol under HS 29335995 and SITC 51576. As of Q4 2014, PRIMIDOLOL remains the US FDA Preferred Term for this commodity. Primidolol bears US NLM identifiers UMLS ID C0071975 and NCI Concept Code C76557. SMILES: O(CC(O)CNCCN1CC(C(=O)[NH]C1=O)C)C1C(CCCC1)C.

